ApprovalTrail

Approval · Notice of Compliance 14167 · 2013

RALGRO: Notice of Compliance 14167

Issued February 28, 2013

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
14167
Date
February 28, 2013
Company
Intervet Canada CorpKirkland, Quebec, Canada
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
ALternate manufacturing site, labaling update
Therapeutic class
Growth promotant

Products in this notice

BrandDINStatus today
RALGRO02137607Marketed

Medicinal ingredients